COVID-19 of Omicron Patient Registry Study

Status

Recruiting

Phases

Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2200060042

Enrollment

Unknown

Registered

2022-05-16

Start date

2022-05-10

Completion date

Unknown

Last updated

2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

case series:none

Eligibility

Sex/Gender

All

Age

18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Aged >18 years; 2. Positive nucleic acid test, confirmed as Sars-Covid-19 infection patient; 3. Volunteer for the experiment.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Key factors affecting the outcome of Omicron patients infected with novel coronavirus;Evolution of the effects of Omicron novel coronavirus on various organ functions;	—

Secondary

Measure	Time frame
Evolution of nucleic acid CT values in critically ill patients (changes in vital signs, blood biochemical tests of various organs, and chest CT);	—

Countries

China

Contacts

Public ContactZhou Quanhong

Shanghai Sixth People's Hospital

zhouanny@hotmail.com+86 13761441463

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026